Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05735639
PHASE4

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

Sponsor: Imperial College London

View on ClinicalTrials.gov

Summary

Endovenous interventions are keyhole operations for varicose veins that are carried out from within the vein itself. Varicose veins are enlarged veins close to the surface of the skin. They are connected to the bigger deeper veins in the leg (known as deep veins). Because of this, operations to close the varicose veins can increase the chance of a blood clot forming in the deep veins. Blood clots in the deep veins happen in around 1 in 50 people after endovenous operations. A clot in the leg can cause swelling, pain, and other long-term problems. If a clot in the leg breaks off and travels to the lungs, it can cause problems with the lung' ability to move oxygen from the air into the blood and may, in rare cases, be life threatening. Varicose vein procedures may carry a slightly higher risk of blood clot formation, and we are currently unsure if current clot reducing medicines are beneficial in preventing blood clots in people having varicose vein procedures. This study will investigate if it is worthwhile prescribing medicines to reduce blood clots after varicose vein procedures.

Official title: THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) - a Multi-centre Assessor-blind Randomised-controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

6660

Start Date

2024-01-22

Completion Date

2026-12-31

Last Updated

2025-05-02

Healthy Volunteers

No

Interventions

DRUG

Dalteparin Sodium

Low molecular weight heparin

DRUG

Tinzaparin Sodium

Low molecular weight heparin

DRUG

Enoxaparin Sodium

Low molecular weight heparin

DRUG

Rivaroxaban

Direct oral anticoagulant

DRUG

Apixaban

Direct oral anticoagulant

DRUG

Dabigatran Etexilate

Direct oral anticoagulant

Locations (1)

Imperial College Hospital NHS Foundation Trust

London, United Kingdom